Research project

101080528 NOSEVAC

Innovative Nasal Vaccines to prevent pathogen colonization and infection in the upperrespiratory tract (NOSEVAC)

Duration: from 01 May 2023 to 30 April 2028 (60 months) Current

With a Public character. It has been granted under a regime of Competitive.

In collaboration with other entities.

Call: HORIZON-HLTH-2022-DISEASE-06-two-stage

Program: Pillar 2-Global Challenges and European Industrial Competitiveness

Leader

Co-IP